vanadates has been researched along with oligonucleotides in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrier, I; Cayrol, R; Gros, P; Julien, M; Rousseau, ME; Urbatsch, IL | 1 |
| Babb, R; Bowen, BR; Whelan, J; Yang, Z | 1 |
| Davis, AE; Liu, D; Prada, AE; Scafidi, J; Zahedi, K | 1 |
| Champoux, JJ; Davies, DR; Hol, WG; Interthal, H | 2 |
| Ahonen, M; Alarid, ET; Carter, D; Fritsch, MK; Murdoch, FE; Weinberg, AL | 1 |
6 other study(ies) available for vanadates and oligonucleotides
| Article | Year |
|---|---|
Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Amino Acid Substitution; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Azides; Binding Sites; Carboxylic Acids; Conserved Sequence; DNA Mutational Analysis; Drug Resistance, Multiple; Genetic Vectors; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligonucleotides; Photoaffinity Labels; Pichia; Vanadates | 2000 |
An mRNA splice variant of the AFX gene with altered transcriptional activity.
Topics: Alternative Splicing; Aminoimidazole Carboxamide; Base Sequence; Blotting, Western; Cell Cycle Proteins; Cell Line; Cloning, Molecular; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Forkhead Transcription Factors; Genes, Reporter; Histidine; Humans; Hypoglycemic Agents; Insulin; Molecular Sequence Data; Oligonucleotides; Phosphorylation; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Binding; Protein Isoforms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Ribonucleotides; RNA, Messenger; Signal Transduction; Subcellular Fractions; Tissue Distribution; Transcription Factors; Transcription, Genetic; Transfection; Vanadates | 2002 |
Nuclear phosphatases and the proteasome in suppression of STAT1 activity in hepatocytes.
Topics: Acetylcysteine; Cell Cycle Proteins; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Cysteine Endopeptidases; DNA-Binding Proteins; Dual Specificity Phosphatase 1; Enzyme Inhibitors; Hepatocytes; Humans; Immediate-Early Proteins; Interferon-gamma; Multienzyme Complexes; Nuclear Proteins; Oligonucleotides; Phosphoprotein Phosphatases; Phosphorylation; Proteasome Endopeptidase Complex; Protein Binding; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Recombinant Proteins; Serpins; Signal Transduction; STAT1 Transcription Factor; Staurosporine; Trans-Activators; Tumor Cells, Cultured; Ubiquitin; Vanadates | 2002 |
Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide.
Topics: Crystallization; Crystallography, X-Ray; DNA; DNA Topoisomerases, Type I; Humans; Hydrogen Bonding; Models, Molecular; Molecular Mimicry; Oligonucleotides; Phosphoric Diester Hydrolases; Protein Conformation; Vanadates | 2003 |
Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes.
Topics: Binding Sites; Crystallography, X-Ray; DNA Topoisomerases, Type I; Ligands; Models, Molecular; Octopamine; Oligonucleotides; Peptides; Phosphoric Diester Hydrolases; Structure-Activity Relationship; Vanadates | 2004 |
The DNA binding domain of estrogen receptor alpha is required for high-affinity nuclear interaction induced by estradiol.
Topics: Amino Acid Substitution; Binding, Competitive; Cell Line; Cell Line, Tumor; Cell Nucleus; Cytosol; DNA; DNA-Binding Proteins; Endonucleases; Estradiol; Estrogen Receptor alpha; Gene Deletion; HeLa Cells; Histone Acetyltransferases; Humans; Nuclear Localization Signals; Nuclear Receptor Coactivator 3; Oligonucleotides; Polyphosphates; Protein Binding; Response Elements; Solubility; Trans-Activators; Vanadates | 2007 |